Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsCancerCancer Diagnostic

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223507

Cover Image

PUBLISHER: Data Bridge Market Research | PRODUCT CODE: 1223507

MEA Thyroid Cancer Diagnostics Market - Industry Trends and Forecast to 2030

PUBLISHED:
PAGES: 230 Pages
DELIVERY TIME: Inquiry
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License) - Printable/Downloadable
USD 3500
PDF (Enterprise License) - Printable/Downloadable
USD 4200

Add to Cart

Description

Table of Contents

List of Tables

The Middle East and Africa thyroid cancer diagnostics market is projected to register a substantial CAGR of 4.8% from 2023 to 2030. The new market report contains data for the historic year 2021, the base year of calculation is 2022, and the forecast period is 2023 to 2030.

Market Segmentation:

Middle East and Africa Thyroid cancer diagnostics Market- By Product type (Instruments, Consumables & Accessories), Test Type (Imaging Test, Blood Test, Biopsy, Others), Cancer type (Papillary Carcinoma, Follicular Carcinoma, Others), Stages (Stage I, Stage II, Stage III, Stage IV), Age Group ( 30-65, 65 and above, 21-29, Below 21), End User (Hospitals, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes, Others), Distribution Channel (Direct Tender, Retail Sales), Country (South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, Rest of Middle East and Africa) Industry Trends and Forecast to 2030.

Some of the major factors contributing to the growth of the Middle East and Africa thyroid cancer diagnostics market are:

Rising incidence and prevalence of thyroid nodules & cancer

Rising thyroid cancer diagnostic tests rise in product approvals

Rising awareness towards thyroid cancer

Market Players:

Some major companies which are dealing in the Middle East and Africa Thyroid cancer diagnostics market are listed below:

FUJIFILM Holdings Corporation

F. Hoffmann-La Roche Ltd

Quest Diagnostics Incorporated

Illumina

Koninklijke Philips N.V.

Thermo Fisher Scientific Inc.

Siemens Healthcare GmbH

Abbott

General Electric Company

QIAGEN

DIASORIN S.P.A.

Merck KGaA

Hologic

Myriad Genetics Inc.

BIOMERIEUX

FONAR Corp.

Show more

TABLE OF CONTENTS

1 INTRODUCTION 46

  • 1.1 OBJECTIVES OF THE STUDY 46
  • 1.2 MARKET DEFINITION 46
  • 1.3 OVERVIEW OF THE MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET 46
  • 1.4 LIMITATIONS 48
  • 1.5 MARKETS COVERED 48

2 MARKET SEGMENTATION 51

  • 2.1 MARKETS COVERED 51
  • 2.2 GEOGRAPHICAL SCOPE 52
  • 2.3 YEARS CONSIDERED FOR THE STUDY 53
  • 2.4 CURRENCY AND PRICING 53
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL 54
  • 2.6 MULTIVARIATE MODELLING 57
  • 2.7 PRODUCT TYPE LIFELINE CURVE 57
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 58
  • 2.9 DBMR MARKET POSITION GRID 59
  • 2.10 MARKET TESTING TYPE COVERAGE GRID 61
  • 2.11 VENDOR SHARE ANALYSIS 62
  • 2.12 SECONDARY SOURCES 63
  • 2.13 ASSUMPTIONS 63

3 EXECUTIVE SUMMARY 64

4 PREMIUM INSIGHTS 67

  • 4.1 PESTEL ANALYSIS 68
  • 4.2 PORTER'S FIVE FORCES 69
  • 4.3 GROWTH STRATEGIES ADOPTED BY KEY MARKET PLAYERS 70

5 EPIDEMIOLOGY 71

6 REGULATORY FRAMEWORK OF THE MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET 72

  • 6.1 REGULATORY SCENARIO IN THE U.S. 72
  • 6.2 REGULATORY SCENARIO IN AUSTRALIA 73
  • 6.3 REGULATORY SCENARIO IN JAPAN 73
  • 6.4 REGULATORY SCENARIO IN CHINA 73

7 MARKET OVERVIEW 74

  • 7.1 DRIVERS 76
    • 7.1.1 RISING INCIDENCE AND PREVALENCE OF THYROID NODULES AND CANCER 76
    • 7.1.2 RISING THYROID CANCER DIAGNOSTIC TESTS 76
    • 7.1.3 RISING PREFERENCE FOR PREVENTIVE HEALTH CHECK-UPS 77
    • 7.1.4 RISING AWARENESS TOWARDS THYROID CANCER 77
  • 7.2 RESTRAINTS 78
    • 7.2.1 HIGH COST OF DIAGNOSTICS PROCEDURE 78
    • 7.2.2 TISSUE DAMAGE DUE TO HIGH RADIATION EXPOSURE FROM IMAGING TESTS 79
  • 7.3 OPPORTUNITIES 79
    • 7.3.1 RISE IN HEALTHCARE EXPENDITURE FOR CANCER DIAGNOSIS AND TREATMENT 79
    • 7.3.2 RISING OBESE POPULATION 80
  • 7.4 CHALLENGES 80
    • 7.4.1 STRINGENT REGULATORY FRAMEWORK FOR THE APPROVAL AND COMMERCIALIZATION OF CANCER DIAGNOSTIC PRODUCTS 80
    • 7.4.2 LACK OF SKILLED AND CERTIFIED EXPERTISE 81

8 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE 82

  • 8.1 OVERVIEW 83
  • 8.2 INSTRUMENTS 86
    • 8.2.1 PATHOLOGY BASED INSTRUMENTS 87
      • 8.2.1.1 PCR INSTRUMENTS 87
      • 8.2.1.2 SLIDE STAINING SYSTEMS 87
      • 8.2.1.3 TISSUE PROCESSING SYSTEMS 87
      • 8.2.1.4 CELL PROCESSORS 88
      • 8.2.1.5 OTHER PATHOLOGY-BASED INSTRUMENTS 88
    • 8.2.2 IMAGING INSTRUMENTS 88
      • 8.2.2.1 ULTRASOUND SYSTEMS 88
      • 8.2.2.2 CT SYSTEMS 88
      • 8.2.2.3 MRI SYSTEMS 88
      • 8.2.2.4 OTHERS 88
    • 8.2.3 BIOPSY INSTRUMENTS 89
      • 8.2.3.1 NEEDLE BIOPSY 89
      • 8.2.3.2 ENDOSCOPIC BIOPSY 89
      • 8.2.3.3 CORE BIOPSY 89
      • 8.2.3.4 OTHERS 89
    • 8.2.4 OTHERS 89
  • 8.3 CONSUMABLES & ACCESSORIES 90
    • 8.3.1 KITS 91
      • 8.3.1.1 PCR KITS 91
      • 8.3.1.2 DNA POLYMERASE KITS 91
      • 8.3.1.3 NUCLEIC ACID ISOLATION KITS 91
      • 8.3.1.4 OTHERS 91
    • 8.3.2 REAGENTS 92
      • 8.3.2.1 ASSAYS 92
      • 8.3.2.2 BUFFERS 92
      • 8.3.2.3 PRIMERS 92
      • 8.3.2.4 OTHERS 92
    • 8.3.3 PROBES 92
    • 8.3.4 OTHER CONSUMABLES 92

9 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE 93

  • 9.1 OVERVIEW 94
  • 9.2 IMAGING TEST 97
    • 9.2.1 COMPUTED TOMOGRAPHY (CT) SCAN 98
    • 9.2.2 MRI 98
    • 9.2.3 POSITRON EMISSION TOMOGRAPHY (PET) SCAN 98
    • 9.2.4 OTHERS 98
  • 9.3 BLOOD TEST 99
    • 9.3.1 BLOOD CHEMISTRY TESTS 100
    • 9.3.2 COMPLETE BLOOD COUNT (CBC) 100
    • 9.3.3 OTHERS 100
  • 9.4 BIOPSY 100
    • 9.4.1 NEEDLE BIOPSY 101
    • 9.4.2 BRONCHOSCOPY BIOPSY 101
    • 9.4.3 CORE BIOPSY 101
    • 9.4.4 OTHERS 101
  • 9.5 OTHERS 102

10 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE 103

  • 10.1 OVERVIEW 104
  • 10.2 PAPILLARY CARCINOMA 107
  • 10.3 FOLLICULAR CARCINOMA 108
  • 10.4 OTHERS 109

11 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY STAGES 110

  • 11.1 OVERVIEW 111
  • 11.2 STAGE I 114
  • 11.3 STAGE II 115
  • 11.4 STAGE III 116
  • 11.5 STAGE IV 117

12 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP 118

  • 12.1 OVERVIEW 119
  • 12.2 30-65 122
  • 12.3 65 AND ABOVE 123
  • 12.4 21-29 124
  • 12.5 BELOW 21 125

13 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY END USER 126

  • 13.1 OVERVIEW 127
  • 13.2 HOSPITALS 130
  • 13.3 ASSOCIATED LABS 131
  • 13.4 INDEPENDENT DIAGNOSTIC LABORATORIES 131
  • 13.5 DIAGNOSTIC IMAGING CENTERS 132
  • 13.6 CANCER RESEARCH INSTITUTES 133
  • 13.7 OTHERS 134

14 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL 135

  • 14.1 OVERVIEW 136
  • 14.2 DIRECT TENDER 139
  • 14.3 RETAIL SALES 140

15 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY REGION 141

  • 15.1 MIDDLE EAST AND AFRICA 142
    • 15.1.1 SAUDI ARABIA 153
    • 15.1.2 U.A.E. 158
    • 15.1.3 SOUTH AFRICA 163
    • 15.1.4 EGYPT 169
    • 15.1.5 ISRAEL 174
    • 15.1.6 REST OF MIDDLE EAST AND AFRICA 179

16 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: COMPANY LANDSCAPE 180

  • 16.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 180

17 SWOT ANALYSIS 181

18 COMPANY PROFILE 182

  • 18.1 CANON INC. 182
    • 18.1.1 COMPANY SNAPSHOT 182
    • 18.1.2 COMPANY SHARE ANALYSIS 182
    • 18.1.3 PRODUCT PORTFOLIO 183
    • 18.1.4 RECENT DEVELOPMENTS 183
  • 18.2 FUJIFILM CORPORATION 184
    • 18.2.1 COMPANY SNAPSHOT 184
    • 18.2.2 REVENUE ANALYSIS 184
    • 18.2.3 COMPANY SHARE ANALYSIS 185
    • 18.2.4 PRODUCT PORTFOLIO 185
    • 18.2.5 RECENT DEVELOPMENT 185
  • 18.3 F. HOFFMANN-LA ROCHE LTD 186
    • 18.3.1 COMPANY SNAPSHOT 186
    • 18.3.2 REVENUE ANALYSIS 186
    • 18.3.3 COMPANY SHARE ANALYSIS 187
    • 18.3.4 PRODUCT PORTFOLIO 187
    • 18.3.5 RECENT DEVELOPMENT 187
  • 18.4 QUEST DIAGNOSTICS INCORPORATED 188
    • 18.4.1 COMPANY SNAPSHOT 188
    • 18.4.2 REVENUE ANALYSIS 188
    • 18.4.3 COMPANY SHARE ANALYSIS 189
    • 18.4.4 PRODUCT PORTFOLIO 189
    • 18.4.5 RECENT DEVELOPMENTS 189
  • 18.5 ILLUMINA, INC. 191
    • 18.5.1 COMPANY SNAPSHOT 191
    • 18.5.2 REVENUE ANALYSIS 191
    • 18.5.3 COMPANY SHARE ANALYSIS 192
    • 18.5.4 PRODUCT PORTFOLIO 192
    • 18.5.5 RECENT DEVELOPMENT 192
  • 18.6 ABBOTT 193
    • 18.6.1 COMPANY SNAPSHOT 193
    • 18.6.2 REVENUE ANALYSIS 193
    • 18.6.3 PRODUCT PORTFOLIO 194
    • 18.6.4 RECENT DEVELOPMENT 194
  • 18.7 BD 195
    • 18.7.1 COMPANY SNAPSHOT 195
    • 18.7.2 REVENUE ANALYSIS 195
    • 18.7.3 PRODUCT PORTFOLIO 196
    • 18.7.4 RECENT DEVELOPMENT 196
  • 18.8 BEIJING O&D BIOTECH CO., LTD. 197
    • 18.8.1 COMPANY SNAPSHOT 197
    • 18.8.2 PRODUCT PORTFOLIO 197
    • 18.8.3 RECENT DEVELOPMENTS 197
  • 18.9 BIOMERIEUX SA 198
    • 18.9.1 COMPANY SNAPSHOT 198
    • 18.9.2 REVENUE ANALYSIS 198
    • 18.9.3 PRODUCT PORTFOLIO 199
    • 18.9.4 RECENT DEVELOPMENTS 199
  • 18.10 DIASORIN S.P.A. 200
    • 18.10.1 COMPANY SNAPSHOT 200
    • 18.10.2 REVENUE ANALYSIS 200
    • 18.10.3 PRODUCT PORTFOLIO 201
    • 18.10.4 RECENT DEVELOPMENT 201
  • 18.11 FONAR CORP. 202
    • 18.11.1 COMPANY SNAPSHOT 202
    • 18.11.2 REVENUE ANALYSIS 202
    • 18.11.3 PRODUCT PORTFOLIO 203
    • 18.11.4 RECENT DEVELOPMENTS 203
  • 18.12 GENERAL ELECTRIC 204
    • 18.12.1 COMPANY SNAPSHOT 204
    • 18.12.2 REVENUE ANALYSIS 204
    • 18.12.3 PRODUCT PORTFOLIO 205
    • 18.12.4 RECENT DEVELOPMENTS 205
  • 18.13 HOLOGIC INC. 206
    • 18.13.1 COMPANY SNAPSHOT 206
    • 18.13.2 REVENUE ANALYSIS 206
    • 18.13.3 PRODUCT PORTFOLIO 207
    • 18.13.4 RECENT DEVELOPMENT 207
  • 18.14 KONINKLIJKE PHILIPS N.V. 208
    • 18.14.1 COMPANY SNAPSHOT 208
    • 18.14.2 REVENUE ANALYSIS 208
    • 18.14.3 PRODUCT PORTFOLIO 209
    • 18.14.4 RECENT DEVELOPMENT 209
  • 18.15 MERCK KGAA. 210
    • 18.15.1 COMPANY SNAPSHOT 210
    • 18.15.2 REVENUE ANALYSIS 210
    • 18.15.3 PRODUCT PORTFOLIO 211
    • 18.15.4 RECENT DEVELOPMENT 211
  • 18.16 MEDONICA CO. LTD 212
    • 18.16.1 COMPANY SNAPSHOT 212
    • 18.16.2 PRODUCT PORTFOLIO 212
    • 18.16.3 RECENT DEVELOPMENT 212
  • 18.17 MINFOUND MEDICAL SYSTEMS CO. LTD 213
    • 18.17.1 COMPANY SNAPSHOT 213
    • 18.17.2 PRODUCT PORTFOLIO 213
    • 18.17.3 RECENT DEVELOPMENTS 214
  • 18.18 MYRIAD GENETICS, INC. 215
    • 18.18.1 COMPANY SNAPSHOT 215
    • 18.18.2 REVENUE ANALYSIS 215
    • 18.18.3 PRODUCT PORTFOLIO 216
    • 18.18.4 RECENT DEVELOPMENTS 216
  • 18.19 PLEXBIO. 217
    • 18.19.1 COMPANY SNAPSHOT 217
    • 18.19.2 PRODUCT PORTFOLIO 217
    • 18.19.3 RECENT DEVELOPMENTS 217
  • 18.20 QIAGEN 218
    • 18.20.1 COMPANY SNAPSHOT 218
    • 18.20.2 REVENUE ANALYSIS 218
    • 18.20.3 PRODUCT PORTFOLIO 219
    • 18.20.4 RECENT DEVELOPMENT 219
  • 18.21 STERNMED GMBH 220
    • 18.21.1 COMPANY SNAPSHOT 220
    • 18.21.2 PRODUCT PORTFOLIO 220
    • 18.21.3 RECENT DEVELOPMENTS 220
Show more
  • 18.22 SIEMENS HEALTHCARE GMBH 221
    • 18.22.1 COMPANY SNAPSHOT 221
    • 18.22.2 REVENUE ANALYSIS 221
    • 18.22.3 PRODUCT PORTFOLIO 222
    • 18.22.4 RECENT DEVELOPMENT 222
  • 18.23 TIME MEDICAL HOLDING. 223
    • 18.23.1 COMPANY SNAPSHOT 223
    • 18.23.2 PRODUCT PORTFOLIO 223
    • 18.23.3 RECENT DEVELOPMENT 223
  • 18.24 THERMO FISHER SCIENTIFIC INC. 224
    • 18.24.1 COMPANY SNAPSHOT 224
    • 18.24.2 REVENUE ANALYSIS 224
    • 18.24.3 PRODUCT PORTFOLIO 225
    • 18.24.4 RECENT DEVELOPMENT 225

19 QUESTIONNAIRE 226

20 RELATED REPORTS 230

LIST OF TABLES

  • TABLE 1 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 61
  • TABLE 2 MIDDLE EAST & AFRICA INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 62
  • TABLE 3 MIDDLE EAST & AFRICA INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 63
  • TABLE 4 MIDDLE EAST & AFRICA PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 63
  • TABLE 5 MIDDLE EAST & AFRICA IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 64
  • TABLE 6 MIDDLE EAST & AFRICA BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 65
  • TABLE 7 MIDDLE EAST & AFRICA CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 66
  • TABLE 8 MIDDLE EAST & AFRICA CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 67
  • TABLE 9 MIDDLE EAST & AFRICA KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 67
  • TABLE 10 MIDDLE EAST & AFRICA REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 68
  • TABLE 11 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 72
  • TABLE 12 MIDDLE EAST & AFRICA IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 73
  • TABLE 13 MIDDLE EAST & AFRICA IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 74
  • TABLE 14 MIDDLE EAST & AFRICA BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 75
  • TABLE 15 MIDDLE EAST & AFRICA BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 76
  • TABLE 16 MIDDLE EAST & AFRICA BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 77
  • TABLE 17 MIDDLE EAST & AFRICA BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 77
  • TABLE 18 MIDDLE EAST & AFRICA OTHERS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 78
  • TABLE 19 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 82
  • TABLE 20 MIDDLE EAST & AFRICA PAPILLARY CARCINOMA IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 83
  • TABLE 21 MIDDLE EAST & AFRICA FOLLICULAR CARCINOMA IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 84
  • TABLE 22 MIDDLE EAST & AFRICA OTHERS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 85
  • TABLE 23 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 89
  • TABLE 24 MIDDLE EAST & AFRICA STAGE I IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 90
  • TABLE 25 MIDDLE EAST & AFRICA STAGE II IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 91
  • TABLE 26 MIDDLE EAST & AFRICA STAGE III IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 92
  • TABLE 27 MIDDLE EAST & AFRICA STAGE IV IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 93
  • TABLE 28 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 97
  • TABLE 29 MIDDLE EAST & AFRICA 30-65 IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 98
  • TABLE 30 MIDDLE EAST & AFRICA 65 AND ABOVE IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 99
  • TABLE 31 MIDDLE EAST & AFRICA 21-29 IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 100
  • TABLE 32 MIDDLE EAST & AFRICA BELOW 21 IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 101
  • TABLE 33 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 105
  • TABLE 34 MIDDLE EAST & AFRICA HOSPITALS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 106
  • TABLE 35 MIDDLE EAST & AFRICA ASSOCIATED LABS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 107
  • TABLE 36 MIDDLE EAST & AFRICA INDEPENDENT DIAGNOSTIC LABORATORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 108
  • TABLE 37 MIDDLE EAST & AFRICA DIAGNOSTIC IMAGING CENTERS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 108
  • TABLE 38 MIDDLE EAST & AFRICA CANCER RESEARCH INSTITUTES IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 109
  • TABLE 39 MIDDLE EAST & AFRICA OTHERS IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 110
  • TABLE 40 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 114
  • TABLE 41 MIDDLE EAST & AFRICA DIRECT TENDER IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 115
  • TABLE 42 MIDDLE EAST & AFRICA RETAIL SALES IN THYROID CANCER DIAGNOSTICS MARKET, BY REGION, 2021-2030 (USD MILLION) 116
  • TABLE 43 MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY COUNTRY, 2021-2030 (USD MILLION) 123
  • TABLE 44 MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
  • TABLE 45 MIDDLE EAST AND AFRICA INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 123
  • TABLE 46 MIDDLE EAST AND AFRICA PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
  • TABLE 47 MIDDLE EAST AND AFRICA IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
  • TABLE 48 MIDDLE EAST AND AFRICA BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 124
  • TABLE 49 MIDDLE EAST AND AFRICA CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
  • TABLE 50 MIDDLE EAST AND AFRICA KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
  • TABLE 51 MIDDLE EAST AND AFRICA REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 125
  • TABLE 52 MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 126
  • TABLE 53 MIDDLE EAST AND AFRICA IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 126
  • TABLE 54 MIDDLE EAST AND AFRICA BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 126
  • TABLE 55 MIDDLE EAST AND AFRICA BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 127
  • TABLE 56 MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 127
  • TABLE 57 MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 127
  • TABLE 58 MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 127
  • TABLE 59 MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 128
  • TABLE 60 MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 128
  • TABLE 61 SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
  • TABLE 62 SAUDI ARABIA INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
  • TABLE 63 SAUDI ARABIA PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 129
  • TABLE 64 SAUDI ARABIA IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 65 SAUDI ARABIA BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 66 SAUDI ARABIA CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 130
  • TABLE 67 SAUDI ARABIA KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
  • TABLE 68 SAUDI ARABIA REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 131
  • TABLE 69 SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 131
  • TABLE 70 SAUDI ARABIA IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 71 SAUDI ARABIA BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 72 SAUDI ARABIA BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 73 SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 132
  • TABLE 74 SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 133
  • TABLE 75 SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 133
  • TABLE 76 SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 133
  • TABLE 77 SAUDI ARABIA THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 133
  • TABLE 78 U.A.E. THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 79 U.A.E. INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 80 U.A.E. PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 134
  • TABLE 81 U.A.E. IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 82 U.A.E. BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 83 U.A.E. CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 84 U.A.E. KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 135
  • TABLE 85 U.A.E. REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 136
  • TABLE 86 U.A.E. THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 136
  • TABLE 87 U.A.E. IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 136
  • TABLE 88 U.A.E. BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 136
  • TABLE 89 U.A.E. BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 90 U.A.E. THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 137
  • TABLE 91 U.A.E. THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 137
  • TABLE 92 U.A.E. THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 137
  • TABLE 93 U.A.E. THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 138
  • TABLE 94 U.A.E. THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 138
  • TABLE 95 SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
  • TABLE 96 SOUTH AFRICA INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
  • TABLE 97 SOUTH AFRICA PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 139
  • TABLE 98 SOUTH AFRICA IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
  • TABLE 99 SOUTH AFRICA BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
  • TABLE 100 SOUTH AFRICA CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 140
  • TABLE 101 SOUTH AFRICA KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
  • TABLE 102 SOUTH AFRICA REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 141
  • TABLE 103 SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 141
  • TABLE 104 SOUTH AFRICA IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 142
  • TABLE 105 SOUTH AFRICA BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 142
  • TABLE 106 SOUTH AFRICA BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 142
  • TABLE 107 SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 143
  • TABLE 108 SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 143
  • TABLE 109 SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 143
  • TABLE 110 SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 144
  • TABLE 111 SOUTH AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 144
  • TABLE 112 EGYPT THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
  • TABLE 113 EGYPT INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
  • TABLE 114 EGYPT PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 145
  • TABLE 115 EGYPT IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
  • TABLE 116 EGYPT BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
  • TABLE 117 EGYPT CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 146
  • TABLE 118 EGYPT KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
  • TABLE 119 EGYPT REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 147
  • TABLE 120 EGYPT THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 147
  • TABLE 121 EGYPT IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 147
  • TABLE 122 EGYPT BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 148
  • TABLE 123 EGYPT BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 148
  • TABLE 124 EGYPT THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 148
  • TABLE 125 EGYPT THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 148
  • TABLE 126 EGYPT THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 149
  • TABLE 127 EGYPT THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 149
  • TABLE 128 EGYPT THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 149
  • TABLE 129 ISRAEL THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
  • TABLE 130 ISRAEL INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
  • TABLE 131 ISRAEL PATHOLOGY-BASED INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 150
  • TABLE 132 ISRAEL IMAGING INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 151
  • TABLE 133 ISRAEL BIOPSY INSTRUMENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 151
  • TABLE 134 ISRAEL CONSUMABLES & ACCESSORIES IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 151
  • TABLE 135 ISRAEL KITS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 151
  • TABLE 136 ISRAEL REAGENTS IN THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 152
  • TABLE 137 ISRAEL THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 152
  • TABLE 138 ISRAEL IMAGING TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 152
  • TABLE 139 ISRAEL BIOPSY IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 152
  • TABLE 140 ISRAEL BLOOD TEST IN THYROID CANCER DIAGNOSTICS MARKET, BY TEST TYPE, 2021-2030 (USD MILLION) 153
  • TABLE 141 ISRAEL THYROID CANCER DIAGNOSTICS MARKET, BY CANCER TYPE, 2021-2030 (USD MILLION) 153
  • TABLE 142 ISRAEL THYROID CANCER DIAGNOSTICS MARKET, BY STAGES, 2021-2030 (USD MILLION) 153
  • TABLE 143 ISRAEL THYROID CANCER DIAGNOSTICS MARKET, BY AGE GROUP, 2021-2030 (USD MILLION) 153
  • TABLE 144 ISRAEL THYROID CANCER DIAGNOSTICS MARKET, BY END USER, 2021-2030 (USD MILLION) 154
  • TABLE 145 ISRAEL THYROID CANCER DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION) 154
  • TABLE 146 REST OF MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION) 155

LIST OF FIGURES

  • FIGURE 1 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: SEGMENTATION 26
  • FIGURE 2 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: DATA TRIANGULATION 29
  • FIGURE 3 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: DROC ANALYSIS 30
  • FIGURE 4 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: MIDDLE EAST & AFRICA VS REGIONAL MARKET ANALYSIS 31
  • FIGURE 5 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS 31
  • FIGURE 6 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS 33
  • FIGURE 7 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID 34
  • FIGURE 8 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: MARKET TESTING TYPE COVERAGE GRID 36
  • FIGURE 9 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS 37
  • FIGURE 10 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: SEGMENTATION 41
  • FIGURE 11 THE INCREASE IN THE AWARENESS ABOUT THYROID CANCER IS EXPECTED TO DRIVE THE MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET IN THE FORECAST PERIOD 42
  • FIGURE 12 PRODUCT TYPE SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET IN 2023 & 2030 42
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET 50
  • FIGURE 14 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2022 58
  • FIGURE 15 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, 2023-2030 (USD MILLION) 59
  • FIGURE 16 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, CAGR (2023-2030) 59
  • FIGURE 17 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY PRODUCT TYPE, LIFELINE CURVE 60
  • FIGURE 18 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2022 69
  • FIGURE 19 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY TEST TYPE, 2023-2030 (USD MILLION) 70
  • FIGURE 20 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY TEST TYPE, CAGR (2023-2030) 70
  • FIGURE 21 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY TEST TYPE, LIFELINE CURVE 71
  • FIGURE 22 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2022 79
  • FIGURE 23 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, 2023-2030 (USD MILLION) 80
  • FIGURE 24 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, CAGR (2023-2030) 80
  • FIGURE 25 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY CANCER TYPE, LIFELINE CURVE 81
  • FIGURE 26 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY STAGES, 2022 86
  • FIGURE 27 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY STAGES, 2023-2030 (USD MILLION) 87
  • FIGURE 28 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY STAGES, CAGR (2023-2030) 87
  • FIGURE 29 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY STAGES, LIFELINE CURVE 88
  • FIGURE 30 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2022 94
  • FIGURE 31 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY AGE GROUP, 2023-2030 (USD MILLION) 95
  • FIGURE 32 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY AGE GROUP, CAGR (2023-2030) 95
  • FIGURE 33 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY AGE GROUP, LIFELINE CURVE 96
  • FIGURE 34 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY END USER, 2022 102
  • FIGURE 35 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY END USER, 2023-2030 (USD MILLION) 103
  • FIGURE 36 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY END USER, CAGR (2023-2030) 103
  • FIGURE 37 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE 104
  • FIGURE 38 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2022 111
  • FIGURE 39 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION) 112
  • FIGURE 40 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030) 112
  • FIGURE 41 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE 113
  • FIGURE 42 MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET: SNAPSHOT (2022) 118
  • FIGURE 43 MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022) 120
  • FIGURE 44 MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2023 & 2030) 120
  • FIGURE 45 MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET: BY COUNTRY (2022 & 2030) 121
  • FIGURE 46 MIDDLE EAST AND AFRICA THYROID CANCER DIAGNOSTICS MARKET: PRODUCT TYPE (2023-2030) 121
  • FIGURE 47 MIDDLE EAST & AFRICA THYROID CANCER DIAGNOSTICS MARKET: COMPANY SHARE 2022 (%) 155
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!